Results and Reports
Browse our Archive for previous reports and resultsWe aim to create value for our shareholders and investors by delivering sustainable returns derived from a purpose-driven business model over time.
Read more about AfroCentric’s performance and prospects in our reports and announcements.
2025
Reports
2024
Reports
Why invest in us
Our diversified business model and growth strategy enable us to achieve sustainable value creation and preservation across the healthcare sector. By leveraging our competitive advantages, we mitigate risks to prevent value erosion.
- AfroCentric is one of the largest health administration businesses in the South African healthcare sector.
- We are an integrated healthcare business and market leader in managed care.
- We are the largest distributor of chronic medicine to government hospitals and clinics.
Our integration into Sanlam’s comprehensive ecosystem represents a competitive edge, reaffirming our commitment to providing affordable medical aid and health insurance solutions.
- We have access to Sanlam’s expansive distribution network and diverse financial products.
- Improved offerings and service quality enhance customer service.
Diversified businesses make AfroCentric more sustainable in a changing healthcare environment. Our model, which includes primary care, medicine, hospitalisation and specialist care, enables the Group to optimise healthcare costs and achieve our mission.
- We position start-ups for success.
- We digitise to enhance efficiencies and improve the client experience.
- AfroCentric is positioned for success in an NHI environment.
SENS
Shareholder calendar
Follow our event itinerary and stay updated with our investor-related actions and events.
Date 
02 September 2025
Event
Interim results publication – SENS
Dividends
AfroCentric has a history of delivering sustainable returns to our shareholders.
– Ordinary share dividend.
| Dividend history | Cents |
| 2024 Final dividend | 6 |
| 2024 Interim dividend | 11 |
| 2023 Final dividend | 0 |
| 2023 Interim dividend | 0 |
| 2022 Final dividend | 17 |
| 2022 Interim dividend | 17 |
| 2021 Final dividend | 17 |
| 2021 Interim dividend | 17 |
| 2020 Final dividend | 17 |
| 2020 Interim dividend | 17 |
| 2019 Final dividend | 17 |
| 2018 Final dividend | 16 |
| 2018 Interim dividend | 16 |
| 2017 Final dividend | 14 |
| 2017 Interim dividend | 14 |
| 2016 Final dividend | 12 |
| 2016 Interim dividend | 12 |
| 2015 Final dividend | 10 |
| 2015 Interim dividend | 10 |
| 2014 Final dividend | 18 |
| 2013 Final dividend | 15 |
| 2012 Final dividend | 10.5 |
| 2011 Final dividend | 9 |
| 2010 Final dividend | 7.5 |
Investor relations contacts
We welcome any feedback and engagement with our shareholders.
Registered address
37 Conrad Road
Florida North
Roodepoort
1709
+27 11 671 2000
Postal address
PO Box 1101
Florida Glen
1708
+27 11 758 7987